Safety evaluation of one whole-cell and three acellular pertussis vaccines in Stockholm trial II.
Heijbel
H
H
Swedish Institute for Infectious Disease Control, Stockholm, Sweden.
Rasmussen
F
F
Olin
P
P
D004168:Diphtheria Toxoid / Q000009:adverse effects; D022422:Diphtheria-Tetanus Vaccine; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000009:adverse effects; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D004311:Double-Blind Method; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D012640:Seizures / Q000139:chemically induced; D013548:Sweden; D013745:Tetanus Toxoid / Q000009:adverse effects; D016896:Treatment Outcome; D017778:Vaccines, Combined / Q000009:adverse effects; D014917:Whooping Cough / Q000517:prevention & control* / Q000628:therapy
D004168:Diphtheria Toxoid; D022422:Diphtheria-Tetanus Vaccine; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D013745:Tetanus Toxoid; D017778:Vaccines, Combined